Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

NANOVIRICIDES, INC. Director's Dealing 2011

Jun 21, 2011

34915_dirs_2011-06-20_d5d7751d-cebb-47a4-8e04-c8bdd49a9379.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NANOVIRICIDES, INC. (NNVC.OB)
CIK: 0001379006
Period of Report: 2011-06-15

Reporting Person: Diwan Anil (Director, President, 10% Owner)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2011-06-15 Common Stock G 11100 $1.38 Disposed 7871100 Direct
2011-06-16 Common Stock G 13000 $1.38 Disposed 7858100 Direct

Footnotes

F1: Does not include 33,360,000 shares of common stock held by TheraCour Pharma, Inc., of which Anil Diwan holds voting and dispositive power.